Rosen Law Firm has announced an investigation into potential securities claims against Anavex Life Sciences Corp. following allegations that the company issued materially misleading business information to investors. This comes after Anavex's board terminated CEO Christopher Missling for cause, citing conduct inconsistent with company policy. Shareholders who purchased Anavex securities may be eligible to join a class action lawsuit seeking compensation without upfront costs. The Rosen Law Firm is experienced in securities class actions and is preparing to represent affected investors.
Anavex Life Sciences Corp. is the subject of a securities class action investigation announcement. For readers following the health sector, here is Pluang's market snapshot as of Sep 24, 2026 02:11 WIB: out of 100 priced US health stocks, 10 rose and 89 fell. Notable movers include AMLX at USD 30.78 with a 1-day change of -6.73%, BNGO at USD 1.71 with a 1-day change of -6.04% and a Pluang order activity of 93% Sell / 7% Buy, and CRSP at USD 55.76 with a 1-day change of -5.54% and a Pluang order activity of 100% Sell / 0% Buy.
NeoVolta reported a weak Q4 with revenue dropping to $13,460 and a loss of $0.24 per share, missing analyst expectations. Despite this, full-year revenue rose 58% to $13.3 million as the company expanded beyond residential markets. The Q4 loss widene...
BlackBerry is expected to report Q3 earnings with an EPS of $0.04 and revenue around $143.55 million, in line with company guidance. The company has a strong track record of beating earnings estimates, driven by growth in its QNX automotive software ...
On September 23, Jaguar Health's stock plunged about 74%, reversing a prior gain, without any confirmed negative news. Alkami Technology's shares fell 19% after ending a strategic review and deciding to remain independent. Other stocks like Cullinan ...
Wheeler REIT (WHLR) surged 190.91% after a 1-for-9 reverse stock split, though no new catalyst was confirmed. Artelo Biosciences (ARTL) rose 74% following a provisional patent application for its obesity drug candidate ART27.13, based on early mouse ...
Costco Wholesale announced $93.9 billion in net sales for its fiscal Q4, up 11.3% from last year, with comparable sales rising 9.4%. The full earnings report on September 24 will reveal membership fees, total revenue, expenses, and profit details. An...
